Serum CHIT1 activity is reported to predict endothelial dysfunction in patients with newly diagnosed, untreated and uncomplicated T2D, while plasma YKL-40 is related with insulin resistance [24,25]. The gene discussed is CHI3L1; the disease is Insulin resistance.